Your browser doesn't support javascript.
loading
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study.
Pour, Ludek; Szarejko, Monika; Bila, Jelena; Schjesvold, Fredrik H; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hájek, Roman; Usenko, Ganna; Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Bakker, Nicolaas A; Richardson, Paul G; Mateos, Maria-Victoria.
Afiliação
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic. pour.ludek@fnbrno.cz.
  • Szarejko M; University Clinical Centre, Department of Hematology and Transplantology, Gdansk.
  • Bila J; Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade.
  • Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo.
  • Spicka I; 1<sup>st</sup> Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic.
  • Maisnar V; 4<sup>th</sup> Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic.
  • Jurczyszyn A; Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Faculty of Medicine, Krakow.
  • Grudeva-Popova Z; Department of Clinical Oncology, Medical Faculty, Medical University of Plovdiv, Plovdic, Bulgaria.
  • Hájek R; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine.
  • Thuresson M; Oncopeptides AB, Stockholm.
  • Norin S; Oncopeptides AB, Stockholm.
  • Jarefors S; Oncopeptides AB, Stockholm.
  • Bakker NA; Oncopeptides AB, Stockholm.
  • Richardson PG; Dana-Farber Cancer Institute, Boston, MA.
  • Mateos MV; Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca.
Haematologica ; 109(3): 895-905, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37646660
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilalanina / Transplante de Células-Tronco Hematopoéticas / Neoplasias de Plasmócitos / Melfalan / Anticorpos Monoclonais / Mieloma Múltiplo / Neutropenia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenilalanina / Transplante de Células-Tronco Hematopoéticas / Neoplasias de Plasmócitos / Melfalan / Anticorpos Monoclonais / Mieloma Múltiplo / Neutropenia Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article